Healthcare

CloudMD (OTC: DOCRF) Continues U.S. Expansion with Acquisition of U.S. Based Chronic Care Medical Clinic

CloudMD will implement its telehealth technology across clinic network Digital healthcare and telemedicine are the great equalizer for healthcare delivery; demand is surging and part of the new normal.  The U.S. recently has made swift […]

Healthcare

Teladoc (NYSE: TDOC) CEO Jason Gorevic: “Pandemic Accelerated Widespread Adoption of Virtual Care”.

      Teladoc Health, Inc. (NYSE: TDOC) Q2 2020 Earnings Call Highlights Jason Gorevic, CEO “…We reported the results of our second quarter, 2020, which was characterized by outperformance across all key financial and operational metrics driven […]

Healthcare

CloudMD (OTC: DOCRF) to Acquire Snapclarity Inc., an Enterprise Mental Health Platform, Expanding Telehealth Offering to Include Mental Wellness

A silent mental health crisis existed before the COVID-19 pandemic and has now been brought to the forefront as a crisis on its own. COVID 19 has created a global focus on mental and physical […]

Healthcare

Valeo Pharma Receives Approval from Health Canada for the Transfer of Commercial Rights to Ametop™

AmetopTM commercialization to begin in July 2020 First of four Valeo products scheduled for launch this summer MONTREAL , July 13, 2020  – Valeo Pharma Inc. (VPH.CN) (“Valeo” or the “Company“), a Canadian specialty pharmaceutical company,  announced today […]

Healthcare

CytoDyn to Prepare a Phase 3 Protocol to Submit to the FDA for a Three-Arm Comparative and Combination Trial of Leronlimab and Remdesivir

VANCOUVER, Washington, May 18, 2020 — Three arms of this trial will be leronlimab, remdesivir, and leronlimab + remdesivir CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), […]

Healthcare

CytoDyn (OTC: CYDY) to Offer No-Cost Exploratory Laboratory Testing for Childhood Inflammatory Disease Associated with COVID-19

VANCOUVER, Washington, May 15, 2020– CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced it is […]

Healthcare

Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn (OTC: CYDY) for Drug Product Used in COVID-19 Clinical Trials

SAN DIEGO, May 5, 2020  —- Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc., […]

Healthcare

CytoDyn (OTC: CYDY) Reports Strong Results from eIND COVID-19 Patients Treated with Leronlimab; Majority of Patients Have Demonstrated Remarkable Recoveries

54 eINDs approved by FDA and 49 patients have been treated with leronlimab thus far VANCOUVER, Washington, Apr 30, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab […]

Healthcare

CytoDyn (OTC: CYDY) Announces Vyrologix as Proprietary Name for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients in the United States

Company appoints Interim Chief Financial Officer VANCOUVER, Washington, Apr 27, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for […]

Healthcare

CytoDyn (OTC: CYDY) Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients

VANCOUVER, Washington, Apr 27, 2020  — During the FDA’s review period, the Company will dedicate all resources to ensure availability of leronlimab for COVID-19 patients; Cancer programs continue with positive results VANCOUVER, Washington, April 27, 2020 […]